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Abstract: Glycine monitoring is gaining importance as a biomarker in clinical analysis due to its
involvement in multiple physiological functions, which results in glycine being one of the most
analyzed biomolecules for diagnostics. This growing demand requires faster and more reliable,
while affordable, analytical methods that can replace the current gold standard for glycine detection,
which is based on sample extraction with subsequent use of liquid chromatography or fluorometric
kits for its quantification in centralized laboratories. This work discusses electrochemical sensors and
biosensors as an alternative option, focusing on their potential application for glycine determination
in blood, urine, and cerebrospinal fluid, the three most widely used matrices for glycine analysis
with clinical meaning. For electrochemical sensors, voltammetry/amperometry is the preferred
readout (10 of the 13 papers collected in this review) and metal-based redox mediator modification
is the predominant approach for electrode fabrication (11 of the 13 papers). However, none of the
reported electrochemical sensors fulfill the requirements for direct analysis of biological fluids, most of
them lacking appropriate selectivity, linear range of response, and/or capability of measuring at
physiological conditions. Enhanced selectivity has been recently reported using biosensors (with an
enzyme element in the electrode design), although this is still a very incipient approach. Currently,
despite the benefits of electrochemistry, only optical biosensors have been successfully reported for
glycine detection and, from all the inspected works, it is clear that bioengineering efforts will play a
key role in the embellishment of selectivity and storage stability of the sensing element in the sensor.
Keywords: glycine; electrochemical sensors; point-of-care; healthcare; biosensing
1. Introduction
Amino acids (AAs) play a key role in regulating the whole-body metabolism, which is essential
for human health, growth, development, and survival [1]. Among all the AAs, glycine is the smallest
one, having only a single hydrogen atom as its side chain. However, glycine is an important AA that
accounts for ca. 11.5% of total AAs and ca. 20% of AA nitrogen in body proteins [2]. Thus, there is a
significant association between glycine and many human disease states [3], which justifies glycine
being one of the most attractive analytes for clinical applications. Conversely, glycine was traditionally
considered a non-essential AA because it can be endogenously biosynthesized within the human body,
primarily in the liver and kidneys [4]. This theory was well proved through isotopic studies that
confirmed that glycine turnover occurs during body metabolism, resulting in glycine converting into
different compounds (i.e., serine, urine, glutamine, alanine, and other AAs) and flowing to different
body parts [5–7].
On the other hand, the amount of glycine endogenously synthetized is not enough to support
body activity and, therefore, modern AA classifications usually term glycine as a conditionally essential
(or semi-essential) AA [4,8]. From a nutritional perspective, insufficiency in dietary glycine intake
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is not detrimental, but a chronic inadequacy may cause severe effects on the functioning of body
organism, including suboptimal growth, impaired immune responses, and other adverse effects on
health and nutrient metabolism [9,10]. Additionally, numerous studies have demonstrated that dietary
supplementation of glycine can improve outcomes in many clinical conditions, because it may help to
prevent the infiltration of inflammatory cells [11], inhibit tumor growth [12,13], and decrease the toxicity
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S‐adenosylhomocysteine. Reproduced from ref. [15]. 
As  the  smallest  and  the  only  non‐chiral  AA,  glycine  presents  a  unique  structure  that  is 
irreplaceable  in  the  framework  construction of many  structural proteins  (e.g.,  collagen  fibril and 
elastin  [16]) and  common metabolites  (e.g., glutathione,  creatine, porphyrins, purines, heme, and 
serine [3]) as well as in the provision of the flexibility necessary for conformational changes in the 




any  change  that  occurs  in  either  its  generation  or  consumption  processes  may  induce  severe 
syndromes  in  the  individual. Up  to  now,  efforts  have  been  directed  to  establish  an  association 
between glycine levels and disease states, with previous research confirming that low plasma glycine 
levels  can  be  related  to  obesity  [18],  diabetes  [18],  decreasing  sleep  quality  [19],  gout  [20],  and 
schizophrenia [21], whereas high levels of glycine result in nonketotic hyperglycinemia (NKH, also 
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s the smallest and the only non-chiral AA, glycine presents a unique structure that is irreplaceable
in the framework construction of many structural proteins (e.g., collagen fibril and elastin [16]) and
common metabolites (e.g., glutathione, creatine, porphyrins, purines, heme, and serine [3]) as well
as in the provision of the flexibility necessary for conformational changes in the active sites of some
particular enzymes [17]. Consequently, glycine is involved in multiple physiological processes that are
related to three crucial functions: cytoprotection, anti-inflammatory responses, as well as body growth
and development [3].
any glycine-related disorders are associated with its synthesis and catabolism, eaning that any
change that occurs in either its generation or consumptio processes may induce severe syndromes
in the individual. Up to now, efforts have been directed to establish an association between glycine
levels and disease states, with previous research confirming t at low plasma glycine levels can be
related to obesity [18], diabetes [18], decreasing sleep quality [19], gout [20], and schizophrenia [21],
w ereas high levels of glycine result in nonketotic hyperglycinemia (NKH, also known as glycine
e cephalopathy) [22]. T erefore, considering the wide diversity of glycine functions and their
involvement in many different organism (essential) pathways, it is ot surprising that glycine is one of
t e most analyzed biomolecules for clinical purposes.
e c rre t ol sta ar a al tical a roac for l ci e etectio i t e cli ical fiel i ol es
sa le extracti ( s all l a / r ri e) a c r at ra ic r fl r etric a al ses i
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ec ical c sts. sequently, t ere is a clear ee f r t e e el e t f relia le i t- f-care
( ) l ci e etecti et s a le t r i e real-ti e i f r ati relate t a atie t’s ealt
stat s. I t is context, this review focuses on the electrochemical detection f glycine as a strategy that
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can easily be implemented in POC devices, specifically considering biosensors (Figure 2). The first
section of this review focuses on the different body fluids where glycine determination is clinically
relevant, reviewing glycine levels and the information about health disorders that can be acquired
from each targeted body fluid. Subsequently, the different electrochemical strategies reported up to
now for glycine determination are critically discussed, with particular emphasis on their suitability for
glycine quantification at the POC level. Finally, electrochemical biosensing is discussed as a potential
alternative that can help toward overcoming some of the analytical drawbacks that are currently
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discussed  as  a  potential  alternative  that  can  help  toward  overcoming  some  of  the  analytical 
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Figure 2. Graphic concept of electrochemical glycine determination  in  the clinical  field. Glycine  is 
analyzed  in CSF, blood or urine  through  its  electrochemical oxidation  and  the obtained data  are 
transferred wirelessly to a phone/tablet. 
2. Main Sources of Clinically Relevant Information 
The  involvement of glycine  in several  inter‐organ metabolic paths results  in  its presence  in 
several  biological  fluids  at  different  concentration  levels.  Table  1  summarizes  healthy  and 
unhealthy levels of glycine expected in different biological fluids, as per reported analyses in the 
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AAs  is present  in serum  than  in plasma and,  therefore, current clinical glycine analysis generally 
prefers the use of plasma over serum [30] to avoid possible interferences. 
As a  fluid excreted  from human body after  regular metabolism, urine  is  considered another 
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Figure 2. ra hic conce t of electroche ical glycine deter ination in the clinical field. lycine is
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transferred irelessly to a phone/tablet.
2. ain Sources of Clinically Relevant Infor ation
The involve ent of glycine in several inter-organ etabolic paths results in its presence in
several biological fluids at different concentration levels. Table 1 summarizes healthy and unhealthy
levels of glycine expected in different biological fluids, as per reported analyses in the clinical
field. Notably, only blood (including plasma and serum), urine, and cerebrospinal fluid (CSF) are
commonly investigated in routine clinical applications corresponding to glycine-related diseases [23–25].
Then, because glycine levels in all the biological fluids are in very similar ranges, the sa e analytical
technique should, in principle, be able to cover the analysis of any fluid. However, this is not the
case, as far as we know, as a consequence of presenting different matrix effects that impede this kind
of universality.
uantitative analysis of glycine in all the biological fluids has been de onstrated to provide
valuable infor ation for the diagnoses of specific diseases and the subsequent onitoring of patients’
rehabilitation [24]. For exa ple, the early identification of K solely relies on the detection of
glycine levels in plas a and CSF [26]. n the other hand, saliva, s eat, and interstitial fluid (ISF) are
also attractive sources of bio arkers that are appealing due to the possibility of being accessed in a
non-invasive ay [27]. Yet, these fluids have not been routinized for glycine detection and there is
rare accessible clinical infor ation regarding hu an glycine levels. In addition, blood-derived fluids
(plas a and seru ) are nor ally e ployed instead of hole blood [28]. hile these t o atrices
see to de onstrate similar characteristics, their A levels are not identical because of different
pre-treatment procedures [29]. Several studies have pointed out that higher and more variable content
of As is present in serum than in plasma and, therefore, current clinical glycine analysis generally
prefers the use of plas a over serum [30] to avoid possible interferences.
s a fluid excreted fro hu an body after regular etabolis , urine is considered another
helpful atrix that gives diagnostic infor ation [31]. Its use could indeed be considered superior
co pared to blood because it is non-invasive, si ple, and ithout require ent of a specially trained
operator. Besides that, urine sa ples could be abundantly supplied (the average value for adult is
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1.5–2.0 L per day) [31]. Along with elevated plasma glycine, an excessive amount of glycine in urine is
also typical among NKH patients. Mixed effect from renal function and drug treatment results in more
variable glycine concentrations in urine, increasing the complexity of data interpretation compared to
plasma [32]. As a result, urine glycine analysis is not generally considered as the primary preference to
collect information for screening an inborn disorder of metabolism [33]. Nevertheless, in some specific
applications, it is crucial to perform such detection [33]. For example, iminoglycinuria is characterized
by elevated glycine levels in urine (along with proline and hydroxyproline), while plasma glycine
remains at a normal level [34]. In conclusion, urinary glycine detection is still of obvious clinical
significance, being used as complementary information to blood-related tests, but also as a unique
diagnosis of some specific diseases.
Table 1. Physiological ranges of glycine concentrations (µM) in different body fluids.
Sample Healthy Levels a UnhealthyLevels a Ref.
Plasma/Blood b
147–299 (men)
100–384 (women) 450–2363 [35,36]
CSF c 3.8–10 <3 and 30–1927 [22,26,35,37]
Urine d 44–300 g 550–5000 [31,38]
Saliva 177.80 ± 143.20 - [39]
Sweat e
1751 ± 150 (passive)
997–595 (exercise) - [40,41]
ISF f
565 ± 92 (adipose)
400 ± 48 (muscle) - [42]
a Literature values differentiate from laboratories and techniques. b Glycine levels in plasma depend on sex and age.
c CSF glycine level also depends on age but with much less differences compared with plasma. d Urinary glycine is
commonly normalized by creatinine concentration. e Sweat glycine levels vary significantly from passive sweat
and sweat after different durations of exercises. f ISF concentration depends on the type of tissue considered.
g µM glycine/mM creatinine.
Compared with other commonly analyzed biological fluids, CSF is harder to access [37] because
its collection requires a lumbar puncture. However, glycine detection in CSF is highly valuable in the
diagnosis of several disorders, among which the most noteworthy is NKH [43]. The confirmation is
normally established by elevated CSF and plasma glycine levels in combination with a CSF-to-plasma
glycine ratio greater than 0.08 (normal ≤ 0.02) [22,44]. The simultaneous collection (within 2 h) of
CSF and plasma is necessary to provide diagnostic information [33,45]: in the collection of CSF,
some precaution should be taken to avoid blood contamination, because this will generate erroneous
elevation of glycine level in the CSF sample, given the much higher blood glycine range, leading to an
invalid result [24].
Overall, blood plasma analysis is currently the preferred assay for clinical glycine detection [25],
because it is informative, relatively easy to access, and reproducible [46]. However, it should be
highlighted that diagnosis of glycine-related diseases is not recommended through the analysis of a
unique biological fluid. Therefore, considering that the combination of different matrix detections is of
great significance in clinical applications, an ideal glycine sensing platform should be compatible with
a variety of biological fluids.
3. Current Analytical Methodologies for the Determination of Glycine
Clinical quantitative determination of glycine in biological fluids is frequently accomplished
by means of liquid chromatography methods [47–49]. Among them, the most common technique is
ion-exchange chromatography (IEC) combined with post-column ninhydrin derivatization [45,49–54],
which is able to convert glycine into a relatively stable chromophore with absorbance at λmax of 570 nm
(Ruhemann’s purple easily detected by ultraviolet spectrophotometry) [45,55]. With the advantages
of high reproducibility and accuracy [54,56], good linearity over a wide range of concentration [24],
sensitivity in the picomole level [24], and complete automation [57], this methodology was considered
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as the gold standard for clinical analysis of glycine (as well as other physiological AAs) over recent
decades [24,44,53]. Notably, some aspects should be critically addressed, aiming at evaluating the real
suitability of this approach:
• Chromatographic methods with optical detection seem to lack specificity towards glycine
determination [24,47]. As separation and identification are exclusively based on the retention
time, there is always a risk of AA coelution [24,45], which could lead to overestimated results.
For example, co-elution of glycine, arginine, histidine, and valine is reported for HPLC when
the ionic strength of the eluent is not properly chosen [56]. Essentially, a careful selection of the
stationary and mobile phases is mandatory to provide appropriate results, which is evidently
more expensive, as a particular combination is exclusively used for only one analyte.
• Sample pre-treatments are complicated while inevitable, namely deproteinization and
derivatization [47,58,59]. The former process is necessary because of the presence of soluble
interferent species, such as peptides and proteins in the fluid, that will encumber the
chromatographic column and give elevated backpressure in the instrument [60]. Accordingly,
these compounds will disturb both quantitative and qualitative analysis, in addition to generating
negative impacts on the instruments. Then, it is essential to include derivatization processes
in column-based methods with optical detection because neither chromophore nor fluorophore
groups are present in the molecular structure of glycine [47,61]. However, this treatment will
bring negative effects to the analysis as well, as a consequence of the presence of derivatized
compounds (impurities) [47].
• A typical IEC AA analysis normally takes several hours due to the fact that a low mobile phase flow
rate is needed (for example 0.25 mL/min [62,63]) [58], which is quite time-consuming [54,59,64].
Furthermore, there is always extra time spent on mobile phase elution between each measurement
for the purposes of removing residual impurities from the previous sample as well as equilibrating
the column before the analysis of a new sample. This long analysis results in an important
delay between the extraction of the sample and the outcomes’ provision, and therefore,
the implementation of any needed medical treatment.
• The instrumentation and maintenance of the IEC instrument (and therefore, the related analyses)
are costly [64]. Chromatographic methods require specialized equipment [48] that small-sized
hospitals and laboratories might not have access to. Furthermore, these techniques demand for
skillful operators that should be capable of implementing testing on the exquisite facilities [59].
The combination of these two aspects implies that glycine analysis is mainly performed in
specific centralized laboratories. Thus, after collecting the sample, transportation to external
laboratories is many times indispensable, resulting in an even extended overall time of test and
data provision [65].
As alternatives to the conventional IEC method, other chromatographic systems have been
proposed in routine glycine analysis [60,66], such as reversed phase high-performance liquid
chromatography (RP-HPLC) with pre-column derivatization [67] and ultra-high-performance liquid
chromatography (UPLC) [68]. Although these approaches have shown shorter operation time (45 min
is reported for UPLC) [68] and higher sensitivities [56], this type of method still displays common
weaknesses related to chromatographic systems, which have just been discussed.
Another well-established tool for glycine detection in biological fluids is a commercial fluorometric
kit that can be acquired from many different providers [69–74]. These fluorometric kits are based
on an enzymatic assay in which glycine is oxidized, yielding a fluorometric product. Notably,
to utilize the intrinsic linear range of calibration offered by the kit, different degrees of dilution are
required for the analysis of serum, urine, and saliva, attending to the different amounts of glycine
(see Table 1). In addition, further dilutions as well as deproteinization of samples may be required to
avoid interferences from proteins and common metabolites present in biological fluids. Apart from
time consumption, this sample pre-treatment is likely to affect the analysis results by introducing
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several systematic errors [27]. Moreover, specific sample volume is necessary to generate strong
enough fluorescence signal, which naturally correlates to a relatively large consumption of reagents in
the kit components. High price and relatively long operation time (sample incubation solely takes 1 h)
make this technology not suitable for extensive application.
With those considerations in mind, modern glycine sensing is currently in demand of the
establishment of a rapid, direct, robust, and simple methodology that can be adapted to POC
platforms. Compared with conventional chromatographic methods, electrochemical sensors depict
unique advantages, such as rapidity, miniaturized size, low cost, and less energy consumption [75–77].
Thereby, this sensing methodology is now attracting more attention and many efforts have been
devoted towards new glycine (bio)sensors. In this direction, the next sections critically review all the
reported electrochemical glycine sensors, pointing out future development possibilities in the field.
Electrochemical Sensors for the Determination of Glycine
Electrochemical sensors for the determination of glycine are usually based on glycine oxidation.
As an aliphatic AA, in the presence of oxygen, glycine can undergo mainly three different oxidation
reactions, as shown in Figure 3, resulting in the formation of glyoxylate, formaldehyde or formic
acid [78]. All these reactions require high oxidation potentials and are not favored at bare carbon
electrodes because of slow electron transfer rate [77,79]. Indeed, very low signals (and even no
signal) with low sensitivity and reproducibility are usually observed at unmodified carbon electrodes.
Therefore, the electrochemical determination of glycine requires an electrocatalyst or redox mediator
to assist in lowering the oxidation potential and increase the electron transfer rate.
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Figure 4. Reactions i volved in the determinati f lycine using a Ni(II) chelidamic acid-mo ified
electrode with the expect d cy lic voltammo i the absence (reaction 4, curve 3) and presence
(reactions 5 and 6, curve 4) of glycine. (The plot voltammograms on the left is repro uced from
reference [61] with permission from Springer, Copyright 2020).
This strategy can be implemented with many amperometric techniques, with chronoamperometry
and differential pulse voltammetry (DPV) being the two most frequent. In terms of analytical
performance, metal complex-based electrodes can provide limits of detection (LOD) in the range of
a few µM and linear ranges of response from a few µM up to approximately 1 mM, even reaching
12 mM in the case of the Fe(III)–Schiff base-modified electrode [79]. These parameters are, in principle,
suitable for the direct determination of glycine on the most common biological fluids, because glycine
levels are usually at the µM range (see Tabl 1). How ver, only the nickel chelidamic acid-modified
electrode was actually applied to the determination of glycine in human serum and, ev n in this
case, the samples had to be diluted (1.5:2 in methanol) and the proteins extracted to minimize
interferences [61]. Furthermore, one of the reasons that prevents the direct determination of glycine in
undiluted biological fluids using these electrodes is that the optimal response of metal complex-based
electrodes is commonly achieved at extreme pH values, either 2 or 13, which differs significantly
from the physiological pH. Therefore, some sample pre-treatment is always needed with this type
of electrodes.
A possible explanation to the lack of applications using the mentioned electrodes in either diluted
or undilut d real samples may be the low selectivity provided by metal complex-based electrodes.
Taking into ac ount the working mechanism previously explained, an increased metal compl x signal
is to be observed not only in the presence of glycine but also i the presence of any other species which
oxidation can be catalyzed by the metal complex. This depends on the type of interaction established
between the metal complex and glycine compared to potential interferences: these electrodes are
usually also responsive to other AAs with similar structure to glycine (e.g., serine, alanine or valine).
Furthermore, the high potentials required for the oxidation of glycine could also allow the oxidation of
other common electroactive species. For example, the Ni(II)–baicalein complex showed important
response towards glucose, ascorbic acid, uric acid, citric acid, and urea [80]. As pointed out in some
reports, this multi-response could b interesting in combination with flow systems or separation
techniques ( uch as chromatogra hy or electrophoresis) with the advantage of avoiding the tedious
derivatization procedures usually required in optical detectors [83,84]. Evidently, this low selectivity is a
serious drawback in pursuing the direct determination of glycine, which is crucial for the development
of POC platforms. This is indeed one of the fields in which electrochemical sensors can make a
remarkable difference.
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Table 2. Electrochemical sensors reported for the determination of glycine.
Sensing Element Technique AnalyticalParameters Interferences Application Ref.
RuHCF/rGO
SWV
Eox = −1.36 V
pH 5














LOD = 82.25 pM










Eox = 0.14 V
pH 7.4
LOD = 0.06 µM
LRR = 0.2–70 µM
Interference from
Cys, Tyr, Phe. None [77]
ZrO2 or SiO2 NPs Potentiometry LOD = 60 µM
Able to determine




ZrO2 NPs Potentiometry NS
Able to determine






Eap = 0.35 V
pH 13
LOD = 0.3 µM
LRR = 1–750 µM
No interference from









Eap = 0.6 V
pH 8.1
LOD = 145 nM
LRR = 0.3–1 µM
Interference from





Eap = 0.42 V
pH 13
LOD = 0.9 µM












LOD = 10.11 nM
LRR = 0.1–1.2 µM
Interference from
Cys, Val, Phe, Ser,







LOD = 4.11 µM
LRR = 3–12200 µM
Interference from
Cys, Val, Phe, Ser,





Eap = 0.55 V
pH 13
LOD = 9.2 µM
LRR = 20–1000 µM
Interference from Val,





LOD = 10.02 µM







Eap = 0.5 V
pH 13
LOD = 30 µM
LRR = 0.1–1.2 mM
Interference from
Arg. No response to
Glu, Leu or Ala
None [81]
Ala: alanine; Asn: asparagine; CV: cyclic voltammetry; Cys: cysteine; DPV: differential pulse voltammetry; Eap:
applied potential; Eox: oxidation peak potential; Gln: glutamine; Glu: glutamic acid; Gly: glycine; GSH: glutathione;
His: histidine; Leu: leucine; LRR: linear range of response; MCM: mobile crystalline material; NP: nanoparticle; NS:
not specified; Phe: phenylalanine; Pro: proline; rGO: reduced graphene oxide; RuHCF: ruthenium hexacyanoferrate;
Ser: serine; SWV: square wave voltammetry; Thr: threonine; Trp: tryptophan; Tyr: tyrosine; Val: valine.
An improved selectivity was achieved with a paraffin-impregnated graphite electrode modified
with ruthenium hexacyanoferrate (RuHCF)/reduced graphene oxide [75]. In this work, the synergy of
reduced graphene oxide with RuHCF provided an improved electrocatalytical performance, being
capable of discriminating between glycine, glutathione, and threonine (i.e., separate peaks for each AA
through DPV). In addition, no interference was observed between the three analytes or from ascorbic
acid, uric acid, dopamine, l-cysteine, aspartic acid, salicylic acid, tartaric acid, or urea. This electrode
was successfully applied to the simultaneous determination of glycine, glutathione, and threonine in a
spiked human saliva sample. However, the matrix had to be diluted 100 times and the pH adjusted to
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5 in order to obtain accurate results, as a result of a very narrow linear range of response (from 1.25 to
7.49 µM), which is indeed too low for the direct analysis of glycine in any undiluted body fluid except
for CSF.
Other voltammetric and amperometric sensors reported for the determination of glycine are
based on metal nanoparticles [86,87], silica mobile crystalline materials [86,88] or biopolymers [77].
Among these, the NiO NPs-modified rotating glassy carbon electrode presented a behavior similar to
metal complex-based electrodes, with an optimized response at pH 13 and similar LOD, although the
linear range of response was narrower (from 1 to 200 µM) and the higher concentration too low for
measuring undiluted samples. Apart from glycine, this electrode was also responsive to alanine and
serine, but with neglected response for threonine, asparagine, histidine, glutamine or proline.
A deeper study regarding AAs interference was carried out by Hasanzadeh et al. [86], using a glassy
carbon electrode modified with magnetic silica mobile crystalline material-41 (Si-MCM-41-Fe2O3).
Oxidation peak potentials were indeed related to the AA structure, observing similar potentials for AAs
containing similar functional groups. Moreover, higher currents were observed when the structure of
the AA allowed a greater interaction with Si-MCM-41-Fe2O3. In particular, glycine was oxidized at
0.83 V, presenting a similar potential as tryptophan. Advantageously, the Si-MCM-41-Fe2O3-modified
electrode presents an optimized response at pH 8.1, which is much closer to physiological pH than
previously described electrodes. Although a much lower LOD was presented, the linear range of
response was again very narrow, only reaching up to 1 µM. Importantly, a slightly lower LOD and
wider linear range of response (0.1–1.2 µM), although still far from the normal levels found in biological
fluids, was obtained at physiological pH by functionalizing Si-MCM-41 with amino groups [88].
Adequate responses at physiological pH with a wide linear range of response up to 70 µM were
observed with a glassy carbon electrode modified with poly-dopamine-beta-cyclodextrin [77]. In this
case, the electrocatalytic effect was a result from the combination of active functional groups in the
surface of poly-dopamine that could easily form hydrogen bonds with the amine groups of glycine,
and the presence of beta-cyclodextrin, which allowed for the inclusion of glycine in its hydrophobic
cavity providing a sort of preconcentration. This was manifested as a decrease in the oxidation
potential of glycine (ca. 0.14 V), which is indeed expected when chemically and orientally favoring the
oxidation process.
Even though voltammetric and amperometric sensors are the most common for the electrochemical
determination of glycine, some sensors based on other electroanalytical techniques have also been
reported. Alam et al. [76] reported on a glassy carbon electrode modified with ZnO/Al2O3/Cr2O3
nanoparticles and interrogated by electrometry at pH 7. Thus, the metallic nanoparticles were able
to electrocatalyze the oxidation of glycine to formaldehyde, giving rise to electrons’ generation that
increased the conductivity of the solution. This method provided a very low LOD (82.25 pM) with
a linear range of response limited to very low concentrations (up to 1 µM). An interference study
showed that the presence of common ions (K+, Na+, Fe2+ or Ca2+) did not affect to the sensor response
but other biomolecules (ascorbic acid, bilirubin, d-fructose, d-glucose, l-cystine, l-glutathione, tannic
acid, and uric acid) strongly affected the electrode response, with no possibility to differentiate among
them. This method was successfully applied to the determination of glycine in spiked human, mice,
and rabbit serum samples.
A different approach was proposed by the group of B. Yaroslavtsev [64,85]. In this case, the
electrochemical determination of glycine was based on Donnan potential sensors using semipermeable
membranes based on cation exchanger architectures (Nafion or MF-4SC). SiO2 and/or ZrO2 nanoparticles
were used as dopants, creating an electrostatic repulsion that results in the widening of the membrane
pores. Thus, glycine is easily transferred from the sample solution to the membrane. Advantageously,
an optimization of the membrane (material, dopant concentration, and doping strategy) allows the
increase in the sensitivity towards glycine, while reducing the interference from potassium (pH > 7)
or protons (pH < 7). Although no information was provided regarding linear range of response,
this methodology seems to work at the mM range. The simultaneous determination of glycine, alanine,
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leucine, and potassium was achieved by combining different pairs of sensors that showed the highest
sensitivity towards each AA and the lowest correlation among them.
4. Towards the Direct and Decentralized Glycine Electrochemical Detection
An ideal POC sensing platform should demonstrate the eight features established by the
ASSURED guidelines [89]: Affordable, Sensitive (minimal false negatives), Specific (minimal false
positives), User-friendly, Rapid, Robust, Equipment-free, and easily Delivered to end users. Currently,
chromatographic methods and fluorometric kits provide high sensitivity, specificity, and robustness,
whereas electrochemical sensors easily fulfil affordability, user-friendliness, and rapidness. However,
as far as we know, none of the available methods for glycine determination in the clinical field are able
to meet simultaneously all the ASSURED criteria.
In the field of electrochemical sensors for glycine determination, the main challenge that needs
to be addressed is selectivity, as discussed in the previous section. The integration of biosensing
elements in such electrodes could be a trustable alternative. This strategy will benefit from the
specificity of enzymes and may help improve the poor selectivity, as already demonstrated for other
common analytes such as glucose, lactate or urea, among others. In this context, biosensors for the
determination of AAs have been recently reviewed by Pundir et al. [90]. The main approaches reported
for electrochemical biosensing of AAs are illustrated in Figure 5. The most common enzymes used in
these biosensors are d-amino acid oxidase (DAAO, EC No. 1.4.3.3) and l-amino acid oxidase (LAAO,
EC No. 1.4.3.2), which are two flavoproteins that convert d-AAs and l-AAs, respectively, into the
corresponding α-keto acids and ammonium using oxygen and releasing hydrogen peroxide. In this
scheme, AA determination is most frequently based on the amperometric detection of hydrogen
peroxide, although sensors that monitor the consumed oxygen or the generated ammonia have also
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is  indeed a particularly sensitive  issue because GO cannot be stored  for  long  term at 4 °C, which 
hampers  its  implementation  in biosensing or commercial biological assays. Nevertheless, enzyme 
i r . Main approaches for the biosensing determination of l-AAs (upper row) and d-AAs
(l er row) based on electrochemical detection.
Strategies based on the amperometric detection of hydrogen peroxide (Figure 5, in green) usually
require the introduction of a redox mediator to decrease the high overpotential associated with the
direct hydrogen peroxide determination, which would favor the interference of other electroactive
species present in the sample. Common redox mediators are based on transition metal compounds,
conducting polymers, and organic dyes-based mediators [93]. In addition, interferences may also be
reduced by introducing a permselective membrane. For example, Lata et al. [94] developed a biosensor
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for total l-AA determination in fruit juices and alcoholic beverages, based on the covalent immobilization
of LAAO onto a carboxylated multiwalled carbon nanotubes/nickel hexacyanoferrate/polypyrrole
hybrid film electrodeposited on the surface of a glassy carbon electrode. In this biosensor configuration,
the hybrid film containing carbon nanotubes, nickel hexacyanoferrate (a Prussian blue analog),
and polypyrrole enhances the electron transfer between the electrode surface and the enzyme, while at
the same time, providing a more biocompatible environment for the enzyme. The proposed sensor
was tested for the determination of l-phenylalanine as a representative l-AA, achieving a LOD of
0.5 µM and a wide linear range of response between 0.5 µM and 100 mM. Negligible interferences
were observed for ascorbic acid, acetic acid, ethanol, citric acid, cysteine, uric acid, glucose, fructose,
sodium, and potassium. However, as this biosensor was proposed for the determination of total l-AA,
the discrimination between different l-AA was not studied. The accuracy of this biosensor was tested
through the determination of several fruit juices and alcoholic beverages, achieving a good correlation
with the results provided by a standard colorimetric method.
More in the clinical field, Zain et al. [95] reported a biosensor based on DAAO that was applied to
the determination of d-serine in rat brain tissue, providing a LOD of 20 nM and a response time of 0.7 s.
In this case, amperometric detection of peroxide hydrogen was carried out at Pt-Ir (90/10%) by applying
a potential of 0.7 V. The use of such high oxidation potential entailed the incorporation of permselective
membranes to avoid interferences. For this purpose, both Nafion and poly-ortho-phenylenediamine
(PPD) membranes were incorporated, which allowed the decrease in the interference from ascorbic acid
(the main interferent) to barely 0.05%. In addition, no interferences were observed for common species
in the central nervous system (CNS), such as l-AA, dopamine, uric acid, DOPAC, 5-hydroxyindole
acetic acid or homovanillic acid. This biosensor did respond to d-alanine with higher sensitivity than
for d-serine, although this interference is not too problematic for brain tissue analysis because the
levels of d-alanine in CNS are about two orders of magnitude lower than those of d-serine. In vivo
measurements were carried out by implanting the developed sensor in the brain of anaesthetized rats.
Although the d-serine values obtained were not fully validated, the performance of the implanted
biosensors was evaluated through the direct injection of 5 µL of 100 mM d-serine next to the sensor,
which resulted in an increase in the current recorded.
Another strategy that allows the amperometric determination of peroxide hydrogen is based on a
bienzymatic configuration, where horseradish peroxidase (HRP, EC 1.11.1.7) catalyzes the reduction in
peroxide hydrogen. This scheme was reported by Domínguez et al. [91], who tested this bienzymatic
configuration for both l-AA and d-AA by modifying composite graphite–Teflon electrodes with
HRP and either LAAO or DAAO. The reduction in peroxide hydrogen was mediated by ferrocene.
These biosensors were individually tested for different l- and d-AAs, achieving LODs in the range of
1–200 µM depending on the considered AA. In general, lower sensitivities were observed for polar
AAs, which authors attributed to the hydrophobic nature of the Teflon present on the surface. Both
biosensors were able to correctly discriminate enantiomers in racemic samples but were unable to
distinguish between different AAs.
Although less common, amperometric biosensors for AA determination may also be based on
the monitoring of the consumed oxygen (Figure 5, in purple). This strategy is usually less popular
due to some drawbacks associated with oxygen monitoring: oxygen concentration is not constant in
real samples and the high concentration of oxygen in aqueous solutions hinders the determination
of low AA concentrations. Nevertheless, Zhang et al. [96] developed a biosensor for homocysteine
determination in human plasma based on DAAO immobilized eggshell membrane and an oxygen
electrode. The proposed biosensor could easily operate at physiological pH and provided a LOD and
linear range of response of 30 µM and 0.05–1.5 mM, respectively. Taking into account that normal
levels of homocysteine in plasma usually range from 5 to 16 µM, the analytical performance of this
biosensor should be further improved before it can be considered for clinical applications. Furthermore,
high interferences were observed for cysteine because it can react with homocysteine to form S–S
bonds, which results in consumption of the dissolved oxygen in the solution.
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Alternatively, potentiometric sensors may also be applied to the determination of AAs. In this case,
AA concentration is indirectly determined by measuring the amount of ammonium ions generated
(Figure 5, in red). Following this strategy, Lee et al. [92] developed a potentiometric biosensor
for l-AA monitoring during yeast autolysis. The proposed biosensor consisted of a nonactin-PVC
membrane, which acted as an ammonium selective membrane, and an enzymatic membrane in which
LAAO was immobilized onto Nylon and cross-linked with glutaraldehyde. Both membranes were
attached to a commercial ammonia electrode and held by a cellulose membrane. High responses
were achieved for l-isomers of phenylalanine, leucine, tryptophane, cysteine, methionine, tyrosine,
and isoleucine, whereas little to no response was observed for glycine, serine, threonine, proline,
glutamate, and aspartate. Within the first group, phenylalanine and leucine showed the widest linear
ranges of response (0.01–10 mM).
Because the main purpose of DAAO- and LAAO-based biosensors is to discriminate between
d-AAs and l-AAs, little attention is usually placed on glycine, being the only non-chiral AA. As a
result, the available literature really lacks biosensors for glycine detection. In fact, to the best of
our knowledge, no electrochemical biosensors have been reported for glycine determination yet.
Although in principle, all three measuring schemes illustrated in Figure 5 could be suitable for glycine
determination, the main aspect that is currently hindering the development of a glycine biosensor is the
lack of a stable enzyme that can selectively catalyze glycine oxidation. Therefore, research on different
types of enzyme, both natural or bioengineered, and their substrate specificity towards glycine is
indispensable for the further development of electrochemical biosensors for glycine determination.
Consequently, some clues regarding alternative enzymes that could be employed in glycine biosensors
will be next provided.
Glycine oxidase (GO, EC No. 1.4.3.19) is a more specific enzyme that has been reported to be
capable for quantitative glycine detection as the basis of either optical biosensors preparation [97] or
colorimetric assays [59]. GO is a flavoenzyme from Bacillus subtills that is composed of four identical
structures, with each one containing noncovalently bound flavin adenine dinucleotide (FAD) [97–101].
GO catalyzes the oxidation reaction of glycine in the presence of water and oxygen following an
analogous mechanism to that illustrated in Figure 5 for DAAO and LAAO. In particular, for glycine,
the reaction results in the formation of glyoxylate [98,101]. Although GO is more specific toward
glycine than LAAO or DAAO, GO is not only active for glycine: GO shares partial substrate specificity
with various flavooxidases, including DAAO and sarcosine oxidase (SOX, EC No. 1.5.3.1), additionally
catalyzing the oxidation of neutral d-AAs (e.g., d-alanine and d-proline) as well as primary and
secondary amines (e.g., sarcosine and N-ethylglycine) [99–101]. Thus, several studies have focused on
increasing GO specificity towards glycine by means of bioengineering. For example, Rosini et al. [97]
engineered a total of 16 single point GO variants, some of them exhibiting improved kinetic parameters
and/or a higher substrate specificity ratio for glycine versus sarcosine. The introduction of multiple
mutations also provided an increased maximal activity on glycine. Importantly, one GO variant with
high specificity towards glycine was applied to the development of a fluorometric biosensor for the
determination of glycine in biological samples. For this purpose, two disposable and commercially
available fluorometric cuvettes were used, the first filled with Red Nile (a dye transducer) and the
second containing the bioengineered GO. The set-up was arranged so that the emission light (450 nm)
passed through GO before reaching Red Nile and recording the fluorescence spectra from 500 to 700 nm.
In the absence of glycine, the oxidized GO absorbs part of the emission light, quenching the original
fluorescence intensity of Red Nile. When glycine is added onto the second cuvette, the FAD cofactor of
GO is reduced and its absorbance decreases, resulting in an increase in the light that reaches Red Nile
and, therefore, in fluorescence intensity. This methodology provided a LOD lower than 0.5 µM and
was successfully applied to the determination of glycine in the U87 human glioblastoma cell line and
human plasma samples, providing similar analytical performance as chromatographic methods, but in
a much faster way (1 s against 60 min). However, the analysis of these biological samples required AA
extraction and anaerobic conditions, which prevents this biosensor implementation as POC platforms.
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Another important factor that needs to be considered in the development of biosensors is the
stability, because there is always a risk of enzyme deactivation due to diverse reasons. For GO, this is
indeed a particularly sensitive issue because GO cannot be stored for long term at 4 ◦C, which hampers
its implementation in biosensing or commercial biological assays. Nevertheless, enzyme tunability
can also result in an improved enzyme stability. Tatsumi et al. [59] developed a GO triple mutant
that retained most of the enzymatic activity during storage for over a year at 4 ◦C. This engineered
GO mutant was applied to the colorimetric determination of glycine, which was based on a double
enzyme scheme. First, glycine was oxidized by GO generating hydrogen peroxide, which in turn,
reacted with N-ethyl-N-(2-hydroxy-3-sulfopropyl)-3-methylaniline (TOOS) and 4-aminoantipyrine in
the presence of HRP, resulting in the formation of a quinoneimine dye that was detected at 555 nm.
This method presented a LOD and a linear range of response of 2.2 µM and 7–600 µM, respectively,
and was successfully applied to the determination of glycine in human plasma. The obtained results
were comparable to those provided by an automated AA analyzer based on chromatography, with the
additional advantages of avoiding derivatization or deproteination pretreatments and providing a
fast analysis (5 min) that can simultaneously be performed on multiple samples using a microplate
reader. In terms of selectivity, this assay was also responsive to sarcosine, N-ethylglycine, d-alanine,
and d-proline. However, some authors have claimed that plasma analysis was not affected because the
concentration of these substances in plasma is less than 1% of that of glycine (alanine and proline are
usually present as l-AAs), although extrapolation to other biological fluids should be taken carefully
as, for example, sarcosine levels in saliva are around 10% of those of glycine [39].
Apart from enzymes, glycine biosensors may also be based on proteins. Zhang et al. [102] recently
developed a fluorescent Forster resonance energy transfer (FRET) glycine sensor using Atu2422 protein
from Agrobacterium tumefaciens as the recognition element. A rational design of this protein allowed
authors to increase the specificity towards glycine, reducing the binding from l-serine and GABA
that is expected from the non-mutated Atu2422 protein. For the construction of the fluorescent
biosensor, the mutated protein was inserted between enhanced cyan fluorescent protein (ECFP)
and Venus-fluorescent protein (Venus), a pair of donor-acceptor fluorophores commonly used in
FRET sensors. Apart from glycine, small changes in the fluorescence ratio were also observed for
leucine, valine, and threonine, although the binding for these three AAs was insignificant in the
concentration range of 0–50 µM and at concentrations ratios AA/Gly > 10. This FRET biosensor was
applied to the determination of glycine transients in acute hippocampal slices prepared from male
Wistar rats, which allowed authors to test predictions about compartmentalization of glycine levels
(i.e., synaptic, presynaptic and extrasynaptic) and investigate the mechanisms controlling glycine
concentrations (e.g., pharmacological inhibition of glycine transporters and stimulation of collateral
synapses at low and high frequencies).
5. Conclusions
Glycine analysis for clinical purposes is currently performed at centralized laboratories by means
of time and cost consuming methodologies, mainly involving chromatography or fluorometric kits.
Electrochemical sensors have been proposed aiming at more rapid and economical glycine analysis.
The majority of these are amperometric sensors based on metal complexes and provide a suitable LOD
for glycine analysis in biological fluids. However, to date, none of the reported glycine electrochemical
sensors have been able to provide the necessary selectivity, linear range of response, and/or capability
to operate at physiological conditions, essential features that are required for the implementation of
electrochemical sensors as POC platforms. An interesting alternative today entirely lacking in the
literature is based on electrochemical biosensors, i.e., containing one enzyme to derivatize the glycine
to electrochemically measurable compounds. While only a few optical biosensors have been reported
for glycine determination, using either GO or Atu2422 protein as sensing elements, we were not able
to find any glycine electrochemical biosensor. A key aspect would be the enhancement of specificity,
kinetic parameters, and storage stability through bioengineered enzymes and proteins in order to
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really put forward this alternative. In particular, the enhanced properties of GO mutations shed light
on the development of electrochemical biosensors that will hopefully provide superior analytical
features compared to already existing chemical sensors, while allowing simpler set-ups to be further
implemented as POC platforms. This process will also require further efforts to adapt glycine sensors
to miniaturized platforms containing the whole electrochemical cell (working, reference, and counter
electrodes) that are able to perform glycine analysis either using really low amounts of sample
(e.g., blood pricking) or based on wearable sensing approaches for a higher frequency monitoring.
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